Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.Cancer Immunology, Immunotherapy : CII|April 2, 2021
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responsesJesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, et al.Molecular Therapy Oncolytics|November 3, 2023
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.Journal of Virology|April 24, 2009
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantationPim L J van der Heiden, Renate de Boer, Dirk M van der Steen, et al.Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.Blood|March 1, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigensKyra J Fuchs, Marian van de Meent, M Willy Honders, et al.Cancers|November 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers, et al.Pageof 7